nasal formulation comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-06-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its chain combines the first seven residues of corticotropin with a C-terminal proline-glycine-proline extension, a modification intended to slow enzymatic breakdown. The free peptide has a molecular mass near 813.9 daltons. It belongs to the class of ACTH-derived fragments studied for central nervous system activity rather than for adrenal steroid stimulation. This structural relationship to a natural hormone fragment is the usual starting point for describing the compound in the literature.
Development took place during the 1980s at institutes of the Russian Academy of Sciences, where peptide fragments of ACTH were screened for cognitive and neuroprotective effects. The compound received regulatory approval in Russia as a nasal preparation, marketed for conditions such as ischemic stroke, transient ischemic attacks, and optic nerve disorders. Registration in other countries has not followed. Most published clinical reports originate from a small number of Russian research groups, and independent replication outside that setting remains limited. The regulatory status therefore differs sharply between Russia and the rest of the world.
Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.
Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.
| Property | Value | Notes |
|---|---|---|
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro | Heptapeptide; ACTH(4-10) analog extended at C-terminus |
| Molecular mass | ~813.9 Da | Free peptide, unmodified |
| Appearance | White to off-white powder | Typical lyophilized solid |
| Solubility | Soluble in water and saline | Also soluble in common aqueous buffers |
| Storage (solid) | -20 °C, desiccated | Protect from moisture and repeated thawing |
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Laboratory descriptions of the material are consistent across suppliers. It appears as a white to off-white lyophilized powder that dissolves readily in water and in polar organic solvents such as dimethyl sulfoxide. Aqueous solutions are clear and colorless at low concentrations. Because the peptide contains methionine, oxidation at the sulfur atom is a recognized degradation pathway, and handling notes usually call for protected, desiccated storage. Reported purity for research-grade lots is generally above 95 percent as measured by reversed-phase high-performance liquid chromatography.
The compound is registered in Russia as a pharmaceutical product, most commonly formulated as a nasal solution, and has been used in that setting since the 1990s. Outside that jurisdiction it is generally handled as a research chemical rather than an approved medicine. Regulatory status therefore differs sharply between countries, and material sold internationally may not correspond to the Russian pharmaceutical formulation. Documentation with commercial samples is typically limited to a certificate of analysis covering purity and identity, not clinical status or local legal classification.
Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.
该化合物于二十世纪八十年代在俄罗斯被开发，相关工作由俄罗斯科学院分子遗传学研究所的研究团队主导。开发目标并非复制 ACTH 的完整激素活性，而是寻找保留其神经作用方向、同时去除促肾上腺皮质激素释放效应的短肽片段。研究记录显示，这一方向促成了多个相关短肽的合成与筛选，而 Semax 是其中被研究最广泛的一个。当地文献常以 Семакс 这一名称指代它。
研究兴趣主要集中在神经营养因子相关的路径上，包括脑源性神经营养因子与神经生长因子的表达变化。部分实验报告称在特定条件下观察到这些因子的水平上升，但具体信号通路和剂量依赖关系仍未完全厘清。多数公开数据来自细胞模型和动物实验，人体对照研究数量有限。因此，该化合物的作用机制在文献中属于活跃讨论，而非已经确立的定论。
Useful metabolites are excluded since they are polar, and in general contain one or more charged groups. The detoxification of the reactive by-products of normal metabolism cannot be achieved by the systems outlined above, because these species are derived from normal cellular constituents and usually share their polar characteristics. However, since these compounds are few in number, specific enzymes can recognize and remove them. Examples of these specific detoxification systems are the glyoxalase system, which removes the reactive aldehyde methylglyoxal, and the various antioxidant systems that eliminate reactive oxygen species.
Carefully research the demand for their potential new product before spending an outlay of company funds. Obtain a patent on the new medicine preventing other companies from producing that medicine for a certain allocation of time. The Inverse Benefit Law describes the relationship between a drug's therapeutic benefits and the socioeconomic status (overall health risk/need) of the population undergoing treatment. The law states that the therapeutic benefit conferred by medical interventions upon a population is inversely proportional to its incidence of disease or socioeconomic need. When designing drugs, the placebo effect must be considered to assess the drug's true therapeutic value. Drug development uses techniques from medicinal chemistry to chemically design drugs. This overlaps with the biological approach of finding targets and physiological effects.
Jay Johnson, previously head coach of the University of Nevada baseball program, succeeded Andy Lopez who retired after the 2015 season. In his first season as head coach, Johnson guided his team to the programs 17th College World Series appearance and 8th championship series appearance. Johnson resigned from the Wildcat program in June 2021 to accept the head coaching job at LSU. This was after leading the Wildcats to a Pac-12 conference championship and the 18th College World Series appearance in program history; they were eliminated in Omaha by Stanford. In July 2021, Chip Hale was named the new head coach of Arizona baseball. Hale played for the Wildcats under Jerry Kindall and was on the 1986 College World Series championship team; he went on to play, coach and manage in the major leagues for several years, serving as manager of the Arizona Diamondbacks in 2015 and 2016, and most recently serving as the third base coach of the Detroit Tigers. Arizona baseball also has a student section named The Hot Corner. Seventy-five former Arizona baseball players have played in the Major Leagues. Famous alums include Terry Francona, Kenny Lofton, Shelley Duncan, Trevor Hoffman, Mark Melancon, Chip Hale, Craig Lefferts, J. T. Snow, Don Lee, Carl Thomas, Jack Howell, Mike Paul, Dan Schneider, Rich Hinton, Ed Vosberg, Hank Leiber, Ron Hassey, Brad Mills, Joe Magrane, Alex Mejia, Dave Baldwin, Brian Anderson, Jack Daugherty, Scott Erickson, Gil Heredia, Casey Candaele, George Arias, and Scott Kingery.
The cost of data loggers has been declining over the years as technology improves and costs are reduced. Simple single-channel data loggers can cost as little as $25, while more complicated loggers may cost hundreds or thousands of dollars.
Sources: en.wikipedia.org
Albania (Entry & Exit stamp may be issued upon request) Australia (Exit stamp issued upon explicit request) China (Exit stamp issued upon request when using e-Gate) Costa Rica (only at Costa Rican airports; different entry and exit stamps are made at the border crossing with Panama) El Salvador Fiji Hong Kong (no entry or exit stamps are issued; instead, landing slips are issued upon arrival only) Iran Israel (no entry or exit stamps are issued at Ben Gurion Airport, instead landing slips are issued upon arrival and departure) Japan (Exit stamp issued upon request & when not using e-Gate since July 2019) Macau (no entry or exit stamps are issued; instead, landing slips are issued upon arrival only) New Zealand South Korea (since 1 November 2016) Panama (only at Panamanian airports; stamps are made at the border crossing with Costa Rica) Republic of China (exit stamp issued upon request & when not using e-Gate) Singapore (no exit stamps since 22 April 2019) Saint Kitts and Nevis Schengen Area countries (when the Entry/Exit System becomes operational, it is anticipated that the passports of third-country nationals will not be stamped when they enter and leave the Schengen Area)
phenotype The composite of the observable morphological, physiological, and behavioral traits of an organism that result from the expression of the organism's genotype as well as the influence of environmental factors and the interactions between the two.
== Toxicity == The toxicity of organomercury compounds presents both dangers and benefits. Dimethylmercury in particular is notoriously toxic, but found use as an antifungal agent and insecticide. Merbromin and phenylmercuric borate are used as topical antiseptics, while thimerosal is safely used as a preservative for vaccines and antitoxins.
=== Models === It was suggested that the problem with building and maintaining larger, more complex, and more accurately replicated molecules can be circumvented if several information carriers, each of them storing a small piece of information, are connected such that they only control their own concentration. Studies of the mathematical model describing replicating molecules revealed that to observe a cooperative behaviour among self-replicating molecules, they have to be connected by a positive feedback loop of catalytic actions. This kind of closed network consisting of self-replicating entities connected by a catalytic positive-feedback loop was named an elementary hypercycle. Such a concept, apart from an increased information capacity, has another advantage. Linking self-replication with mutual catalysis can produce nonlinear growth of the system. This, first, makes the system resistant to so-called parasitic branches. Parasitic branches are species coupled to a cycle that do not provide any advantage to the reproduction of a cycle, which, in turn, makes them useless and decreases the selective value of the system. Secondly, it reinforces the self-organization of molecules into the hypercycle, allowing the system to evolve without losing information, which solves the error threshold problem.
Researchers in safety-critical AI have proposed using architectural redundancy and design diversity to reduce the risk that a single faulty, compromised, or deceptive model causes harm. In such approaches, multiple independently developed or trained models process the same task, and a voter or consensus mechanism combines their outputs rather than relying on a single model.
Sources: en.wikipedia.org
Semax is a synthetic seven-amino-acid peptide derived from a fragment of corticotropin. It is used in Russia as a nasal preparation, while elsewhere it is studied as a research compound. It is not approved as a medicine in most countries.
Its sequence corresponds to the 4-10 region of corticotropin extended by three residues. This fragment lacks the region responsible for adrenal steroid release, so it is explored for neural rather than hormonal effects. The relationship explains the compound's classification among ACTH-derived peptides.
It holds approval in Russia for several neurological indications as a nasal spray or drop formulation. Regulatory agencies in the United States and the European Union have not approved it. Products sold elsewhere are generally labeled for research use only.
It is a short synthetic peptide built from seven amino acids: methionine, glutamic acid, histidine, phenylalanine and three prolines. The sequence derives from the 4-10 fragment of adrenocorticotropic hormone with an added proline-glycine-proline tail. No plant or animal extract is involved; the material is produced by solid-phase peptide synthesis.